For some patients with serious cancers, immunotherapies have provided dramatic results, the Associated Press writes. But, it notes that such treatments might only give temporary relief, don't work for everyone, and can actually make the situation worse for some. Plus, they can be expensive. And so, the AP adds, patients want to know if it'll work for them.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.